BAY-754

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameBAY-754

Drug Alias Nameanaplastic lymphoma kinase 1 inhibitors (Bayer)ALK-1 inhibitors (Bayer)BAY-754

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAnaplastic lymphoma kinase inhibitors

TargetsAnaplastic lymphoma kinase

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

ATC CodeN/A